The T-cell receptor (TCR) recognizes a complex ligand comprised of peptide antigens bound to major histocompatibility complex (MHC) molecules on the surface of antigenpresenting cells. Antigenic peptides are generated from foreign proteins by the cellular processing machinery and are transported to the cell membrane in association with MHC molecules (3, 9) . The T-cell response to complex protein antigens is often limited to only a small number of the potential epitopes, a phenomenon referred to as immunodominance (46) . It has been proposed that the immunodominance of antigenic peptides can be controlled by multiple factors, including selective generation of peptides by antigen processing, different affinities of peptides for MHC molecules, and the available TCR repertoire. Binding of processed peptides to MHC molecules, originally termed determinant selection, has been shown to influence the immunodominance of both class I-and class II-restricted peptides (1, 6, 7, 30, 36, 37, 42) . However, there is little evidence supporting the concept that the TCR repertoire can influence epitope immunodominance, particularly in cases of natural infection.
The experiments described here were designed to directly test the influence of the TCR repertoire on the immunodominance of class I-restricted epitopes generated during the course of an influenza virus infection. We have compared the CD8 ϩ T-cell response to influenza virus infection in TCR ␤-chain transgenic mice that express a rearranged ␤-chain (V␤8.1D␤2J␤2.3C␤2) on Ͼ95% of all peripheral T cells (TG8.1 mice) (8) and their wild-type littermates. We have previously shown that, despite their restricted TCR repertoire, the TG8.1 mice generate influenza virus-specific cytotoxic T cells (CTL) and can clear virus from the lungs with only slightly delayed kinetics compared with their wild-type littermates (15) . The transgenic ␤-chain expressed in these mice was isolated from a D d -reactive T-cell hybridoma that was not specific for influenza virus, and our previous studies have shown that V␤8.1 ϩ T cells are not preferentially used in the influenza virus-specific response in wild-type mice, indicating that we have not inadvertently selected a TCR ␤-chain biased for influenza virus reactivity. Because the TG8.1 mice are genetically identical to wild-type mice except for expression of the transgene, this experimental system has allowed us to examine the effects of the TCR repertoire on the immunodominance of naturally processed class I-restricted epitopes independently of other genetic factors. The data show that the TCR repertoire has a profound effect on epitope selection during the course of a viral infection.
MATERIALS AND METHODS
Mice. The V␤8.1 transgenic mice (TG8.1) used in these experiments express a transgenic TCR ␤-chain (V␤8.1D␤2J␤2.3C␤2) on Ͼ95% of peripheral T cells and have been extensively characterized (8). The transgene, which is carried heterozygously, has been repeatedly backcrossed for Ͼ30 generations onto the CBA/CaJ (H-2 k ) strain. Nontransgenic (wild type) littermates are used as control mice in these experiments. The transgenic breeding colony is maintained at St. Jude Children's Research Hospital. All mice were between 8 and 12 weeks of age at the time of challenge and were maintained under specific-pathogen-free conditions prior to infection.
Virus infection and titration. The A/HKx31 (H3N2) influenza A virus is a recombinant between A/PR8 (H1N1) and A/Aichi (H3N2) and expresses many of the internal components of A/PR8 (22) . The A/HKx31 strain was grown in the allantoic cavity of 10-day-old embryonated hen's eggs. Virus stocks, stored at Ϫ70ЊC as allantoic fluid, were shown to be free of mycoplasma and endotoxin and were counted in a standard hemagglutination assay. Mice were infected intranasally under 2,2,2-tribromoethanol anesthesia with 30 l of phosphatebuffered saline containing 240 hemagglutinating units (HAU) of A/HKx31, as described previously (15) . Vaccinia virus recombinants expressing individual influenza virus proteins were described previously (39) and were a generous gift from J. Bennink (National Institutes of Health, Bethesda, Md.). Monolayers of L(TK Ϫ ) cells were infected at a multiplicity of infection (MOI) of 1 and cultured for 48 h. Cultures were harvested by centrifugation, and cell pellets containing the virus stocks were titered for viral activity by plaque-forming assays on L(TK Ϫ ) cells. Synthetic peptides. The influenza virus nucleoprotein peptide NP 50-57 (SDYEGRLI) (18) was synthesized at St. Jude Children's Research Hospital Molecular Resources Center by fast fMOC chemistry on an ABI model 431A peptide synthesizer (Applied Biosystems Inc., Berkeley, Calif.). The peptide was diluted in water, and the concentration was calculated by using the molar extinction coefficient of tyrosine at a wavelength of 274 nm. The final peptide concentrations used in the assay were 50 to 100 M.
T-cell hybridomas. Mediastinal lymph nodes were pooled from 6 to 10 wildtype or TG8.1 CBA/CaJ mice 4 weeks after intranasal infection with A/HKx31. CD8 ϩ T cells were purified by nylon wool followed by panning on tissue culture flasks (Primaria; Becton Dickinson, Oxnard, Calif.) coated with anti-CD4 antibody GK1.5 (14) as previously described (11) and stimulated twice in vitro with A/HKx31-infected irradiated syngeneic splenocytes in the presence of 30% interleukin-2 (IL-2) supernatant. Activated cells were purified on LSM Lymphocyte Separation Medium (Organon Teknika Corporation, Durham, N.C.) and fused with the TCR-negative variant of the T-cell thymoma BW5147 (43) . Hybridomas were selected in HAT (hypoxanthine-aminopterin-thymidine medium; Gibco BRL, Grand Island, N.Y.) and cultured under limiting-dilution conditions. Clonal hybridomas expressing ␣␤ TCR were analyzed for influenza virus specificity in a standard IL-2 assay. The wild-type and TG8.1 hybridomas reported here were generated from three and four independent fusions, respectively.
IL-2 assay. T-cell hybridoma cells were cocultured for 24 h in a final volume of 250 l in complete tumor medium (21) . When influenza virus-infected stimulators were used in the assay, cells were infected with 25 l of virus (200 HAU/10 5 cells). Cultures were incubated for 4 h and irradiated prior to use in the assay. When vaccinia virus-infected stimulators were used in the assay, L929 cells were infected (MOI of 2 to 5), and 8 to 18 h later, the cells were washed, counted, and irradiated prior to use. Culture supernatants were assayed for IL-2 content as previously described (41, 44) . One unit of human recombinant IL-2 (R&D Systems, Minneapolis, Minn.) represents 160 U in our assay. The limit of detection of our assay is 10 U/ml. Each hybridoma was assayed a minimum of three times, and the data presented in Tables 1 and 2 are from single representative experiments. Borderline values of 10 to 20 U/ml were interpreted in the context of reactivity to the same stimulating cells in replicate experiments and in the context of reactivity to different stimulating cells in the same assay.
Isolation of BAL cells. Seven days postinfection with influenza virus, pooled bronchoalveolar lavage (BAL) cells were obtained from the lungs of 5 to 10 anesthetized mice as described previously (2) . BAL cells were washed once, counted, and allowed to adhere to plastic for 90 min at 37ЊC to remove most of the macrophages. The non-adherent BAL cells were collected, washed, and prepared for use in cytotoxicity assays.
Cytotoxicity assays. Influenza virus A/HKx31-infected (4,000 HAU/10 7 cells for 4 h), vaccinia virus-infected (MOI of 2 for 4 h), or uninfected L929 cells were used as targets for cytotoxicity. Cells were labeled with 100 to 200 Ci of Na 2 51 CrO 4 (Amersham, Arlington Heights, Ill.) overnight and washed three times prior to use. In a typical assay, 5 ϫ 10 3 target cells in 100 l of medium were incubated with various dilutions of effector cells in a final volume of 200 l in 96-well round-bottomed plates. Assays were incubated for 6 h at 37ЊC in 10% CO 2 . After incubation, 100 l of supernatant was collected, and the percent specific 51 Cr release was calculated by the formula: % specific release ϭ [(experimental Ϫ spontaneous)/(maximum Ϫ spontaneous)] ϫ 100 cpm. Spontaneous release was typically less than 20% of the total release induced by 1% Triton X-100.
TCR usage. TCR usage was determined by flow cytometry, PCR amplification, and DNA sequence analysis. The anti-TCR monoclonal antibodies (MAb) have been described previously (12, 13) and identify V␤2-11, -13, and -14 and V␣2 and -8 elements. Stained cells were analyzed with a FACScan (Becton Dickinson, Mountain View, Calif.). Assignment of V␣ and V␤ family members that could not be determined with the panel of antibodies was carried out by reverse transcriptase-PCR with primers that are specific for individual V␣ and V␤ elements, as previously described (11, 13). Cytoplasmic RNA was isolated from each hybridoma by Nonidet P-40 lysis (16) and converted to cDNA by reverse transcription (Boehringer Mannheim, Indianapolis, Ind.) with primers specific for either C␣ or C␤. This cDNA served as a template for PCR amplification on a protocol of 94ЊC for 1 min (denaturation), 55ЊC for 2 min (annealing), and 72ЊC for 3 min (extension) for a total of 28 cycles. PCR products were visualized on 1% agarose gels. When multiple V elements of the predicted size were identified by PCR, bands were purified with Magic PCR preps (Promega, Madison, Wis.) and cloned into the TA cloning vector (Invitrogen, San Diego, Calif.) for sequencing. Sequencing of double-stranded plasmids containing PCR products was carried out with Sequenase (United States Biochemicals, Cleveland, Ohio) in the dideoxy chain termination method of Sanger et al. (35) .
RESULTS
Transgenic and wild-type hybridomas recognize distinct viral epitopes. In order to characterize the influenza virus epitopes recognized by TG8.1 and wild-type littermates, we infected each strain of mouse intranasally with influenza virus A/HKx31. Mediastinal lymph nodes were removed 4 weeks postinfection, and CD8 ϩ T cells were stimulated twice in vitro with influenza virus-infected syngeneic splenocytes. Proliferating cells were fused with the TCR ␣␤-negative variant of the T-cell thymoma BW5147. Altogether, 11 wild-type and 16 transgenic hybridomas that recognized influenza virus-infected
To identify which influenza virus epitopes were recognized, we tested the hybridomas for their responses to L929 cells infected with recombinant vaccinia virus strains expressing three individual influenza virus hemagglutinin isotypes (Vac-H1, Vac-H2, and Vac-H3), neuraminidase (Vac-NA), two matrix proteins (Vac-M1 and Vac-M2), nucleoprotein (Vac-NP), nonstructural proteins (Vac-NS-1 and Vac-NS-2), and acidic and basic polymerases (Vac-PA, Vac-PB-1, and Vac-PB-2) ( Table 2 ). Concomitantly, the MHC class I restriction of the hybridomas was determined by assaying their ability to recog-
) cells in a standard IL-2 assay (Table 1) . Consistent with published data, wild-type hybridomas recognized PB-1 in the context of D k (six hybridomas) and Vac-NP in the context of K k (five hybridomas) (6, 7, 30). The NP/K k -reactive hybridomas were subsequently found to be specific for the previously defined peptide NP 50-57 (18) or an as yet unidentified peptide from NP (data not shown) ( Table 3 ). In contrast, none of these epitopes were recognized by the transgenic hybridomas, which were specific for NS-1 in the context of K k (11 hybridomas) and M1 in the context of D k (5 hybridomas) (Table 3 ). This reciprocal pattern of epitope recognition was evident in hybridomas from several independent fusions, which argues against the possibility that the differences in epitope recognition were due to inadvertent selective outgrowth of T cells during the in vitro culture prior to fusion. Vaccinia virus recombinants expressing influenza virus H1, H2, H3, NA, M2, NS-2, PA, and PB-2 were not recognized by any of the wild-type or transgenic hybridomas tested (data not shown). These results indicate that the expression of the transgenic TCR ␤-chain affects the recognition of viral antigens and determines the immunodominance of influenza virus epitopes. However, expression of the transgene did not affect the relative usage of class I restriction molecules by the hybridomas. The data showed that both K k and D k were used as restriction elements for viral antigen recognition irrespective of whether the hybridomas were derived from TG8.1 or wild-type mice (Table 1) . Therefore, the expression of the transgenic TCR ␤-chain by T cells, while affecting the selection of viral epitopes, did not skew class I restriction element usage by these hybridomas.
Influenza virus epitope specificity of freshly isolated bronchoalveolar lavage CTL. To confirm the results of the hybridoma analysis, we examined the antigenic specificities of influenza virus-specific BAL T cells, isolated directly from the lungs of infected mice. Cells were assayed in a standard cytotoxicity assay in vitro with L929 cells infected with influenza virus or the vaccinia virus recombinants described above (Fig.  1) . Influenza virus-infected targets were readily lysed by both These data clearly showed that the pattern of epitope recognition determined by analysis of T-cell hybridoma specificity was also characteristic of freshly isolated CTL and that the use of a limited TCR repertoire affected the selection of immunogenic epitopes during influenza virus infection. Influenza virus-specific transgenic hybridomas have very limited TCR diversity. In order to compare TCR usage between the transgenic and wild-type hybridomas, we examined TCR expression by antibody and PCR analysis ( Table 3) . As expected, all of the TG8.1 hybridomas (16 of 16) expressed the V␤8.1 transgene and no other TCR ␤-chain. However, V␤ expression was more varied in the panel of wild-type hybridomas. Consistent with our previous report on V␤ expression in BAL cells of influenza virus-infected wild-type mice (15), V␤8.1 is not used extensively in wild-type influenza virus-specific hybridomas (1 of 11). Furthermore, sequence analysis showed that the V␤8.1 ϩ chain expressed in the wild-type hybridoma differed from the transgenic V␤8.1 ϩ chain in non-V␤ element usage (data not shown). Analysis of TCR ␣-chain expression is potentially more ambiguous because there are few available antibodies to detect the expressed V␣ protein, and we (40) and others (19, 26, 29, 32) have shown that multiple ␣-chain rearrangements, resulting in more than one ␣-chain expressed in a single T cell, are possible. However, with the exception of three hybridomas for which we were unable to identify a TCR ␣-chain transcript with any primer used, our analysis showed only a single PCR product of the predicted size. The data showed that TCR expression in the hybridomas derived from TG8.1 mice was extremely limited. Eleven NS-1-specific hybridomas that were generated in two separate fusions expressed V␣4 in conjunction with the transgenic TCR ␤-chain (Table 3) . Sequence analysis of 10 of these chains showed that all expressed the same J␣ element (J␣32) (23) and had identical N-region amino acids encoded by five different nucleotide sequences (Table 4 ). The conservation of non-germline-encoded amino acids suggests that there was a strong selection for this TCR correlated with recognition of NS-1. Similarly, there was limited diversity in the TCR of TG8.1 hybridomas that recognized M1, in that these hybridomas expressed only V␣5 ϩ ␣-chains paired with the transgenic TCR ␤-chain. The sequence of the V␣5 chain expressed by two hybridomas that were generated in separate fusions (K13.8.F6 and K25.22) was identical at the nucleotide level (data not shown). a Influenza virus-specific T-cell hybridomas generated from mediastinal lymph node wild-type (WT) and transgenic (TG) T cells were analyzed for the ability to recognize L929 cells, SVCOLE8 cells, and CH12.1.16 cells infected (I) with influenza virus A/HKx31. The haplotype of the MHC class I molecules expressed by each cell line is shown in parentheses. Uninfected cells (U) were used as a negative control, and TCR ligation with anti-TCR MAb H57-597 was used as a positive control. The values represent the IL-2 secreted by each hybridoma when challenged with each stimulus. The data presented are from one of three independent experiments. The limit of detection of the assay is 10 U/ml. IL-2 production below the level of detection is shown as a dash (-).
b On the basis of cumulative data, 10 to 20 U/ml was considered a negative response. c On the basis of cumulative data, 10 U/ml was considered a positive response. 
DISCUSSION
We have previously demonstrated that CBA/CaJ (H-2 k ) mice expressing a transgenic TCR ␤-chain on Ͼ95% of all peripheral T cells can generate CD8 ϩ cytotoxic T cells in response to influenza virus infection and can clear virus from the lungs with only slightly delayed kinetics compared with wild-type H-2 k mice (15). Our current studies show that the limited TCR repertoire in the TG8.1 mice profoundly affected the immunodominance of class I epitopes following influenza virus infection. Analysis of influenza virus-specific T-cell hybridomas generated from wild-type and transgenic mice revealed a complete switch in epitope selection between the two strains of mice. T-cell hybridomas from wild-type mice exclusively recognized epitopes within NP and PB-1, whereas hybridomas from transgenic mice exclusively recognized epitopes within NS-1 and M1 (Table 2 ). These nonoverlapping patterns of epitope recognition were confirmed in cytotoxicity assays with freshly isolated BAL cells (Fig. 1) , demonstrating that the patterns of epitope specificity seen in the panels of hybridomas were not a consequence of the in vitro culture of virus-specific T cells necessary to generate the hybridomas. This skewing of immunodominance was due solely to the constraints imposed by limited TCR ␤-chain expression and was not due to differences in antigen processing, peptide affinity for MHC, or tolerance, because the mouse strains are genetically identical except for expression of the TG8.1 ␤-chain.
It is likely that the switch in immunodominance seen in the TG8.1 mice is explained by a reduction in the T-cell response to NP and PB-1. Because the V␤8.1 chain used in the TG8.1 mice was not selected for influenza virus specificity, it is possible that the transgenic mice have a reduced frequency or complete absence of NP-or PB-1-specific T cells or that the expression of the transgenic ␤-chain reduces the affinity of T cells specific for NP and PB-1 so that they are not seen after influenza virus infection. Consistent with this hypothesis, there was strong selective pressure on the immune response to influenza virus infection in these mice, in that the repertoire of T cells responding to the NS-1 and M1 epitopes that were recognized in TG8.1 mice was extremely limited (Tables 3 and 4) . For example, all of the NS-1-specific TG8.1 hybridomas expressed identical TCR ␣-chains at the amino acid level, yet they were encoded by five different nucleotide sequences in the non-germline-encoded junctional regions (Table 4 ). This limited ␣-chain usage is not a consequence of restricted ability of ␣-chains to pair with the transgenic ␤-chain, because our previous studies have demonstrated that the TG8.1 ␤-chain can pair with a diverse repertoire of ␣-chains (40) . Rather, the limited TCR ␣-chain usage seen in these hybridomas is a 
Ͼ1,280
a Influenza virus-specific T-cell hybridomas generated from mediastinal lymph node wild-type (WT) and transgenic (TG) T cells were analyzed for the ability to recognize L929 cells infected with influenza virus A/HKx31 or vaccinia virus recombinants expressing individual influenza virus A proteins. Vaccinia virus recombinants expressing influenza virus H1, H2, H3, NA, M2, NS-2, PA, and PB-2 failed to stimulate IL-2 production from any of the hybridomas tested (data not shown). Uninfected L929 cells were used as a negative control, and TCR ligation with anti-TCR MAb H57-597 was used as a positive control. The values represent the IL-2 secreted by each hybridoma when challenged with each stimulus. The data presented are from one of three independent experiments. IL-2 production below the level of detection (Ͻ10 U/ml) is shown as a dash (-).
b On the basis of cumulative data, 10 U/ml was considered a positive response. c NT, not tested.
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on February 23, 2013 by PENN STATE UNIV http://jvi.asm.org/ function of the constraints imposed on antigen recognition by expression of the transgenic ␤-chain. Therefore, an important conclusion from our analysis is that limiting the TCR repertoire causes a switch in the immunodominance of viral epitopes but, in doing so, does not affect the outcome of the influenza virus infection. Other studies have examined the effect of restricting the TCR repertoire on the ability to respond to various antigens. For example, in one study, drastic reduction in the TCR repertoire as a consequence of a genetic deletion in the ␤-chain locus encompassing D␤2-J␤2 (24) failed to eliminate responsiveness to any of 22 different antigens tested, demonstrating the plasticity of the TCR repertoire (45) . In contrast, a separate report showed that the same strain of mice failed to respond to myelin basic protein, indicating a ''hole'' in the repertoire (25) . In addition, mice with a genetic deletion in the V␤ locus that encompasses half of the V␤ genes (5) were unable to respond to a sperm whale myoglobin peptide and a peptide of myelin basic protein, indicating a lack of T cells capable of recognizing these epitopes (27) . Our studies reveal an additional aspect of the plasticity of the TCR repertoire, namely, that a constraint in TCR diversity can be readily compensated for by a switch in epitopes recognized. Importantly, although TG8.1 mice responded to a completely different set of epitopes, this had little effect on the efficiency of the CTL response to influenza virus. The ability to clear virus was not mediated by antibody or CD4 ϩ cytotoxic T cells, because our previous studies have shown that TG8.1 mice depleted of CD4 ϩ T cells clear influenza virus with kinetics comparable to those in undepleted mice (15) . Thus, plasticity in response to complex protein antigens can be demonstrated not only at the level of T-cell diversity but also at the level of the antigenic epitope to which the T cells can respond.
We have shown that influenza virus infection of wild-type H-2 k mice does not elicit T cells specific for NS-1 or M1 ( Fig.  1 and Table 2 ). Presumably this is not due to the absence of 
a Amino acid sequences (top lines) and nucleotide sequences (bottom lines) of the V␣-J␣ junctions of TCR ␣-chains of NS-1-specific TCR ␤-chain transgenic T-cell hybridomas. Nucleotides in the junction regions that vary among the hybridomas are indicated in boldface.
b K11.2.E10, K11.2.G11, and K14.12.C9 (from two separate fusions) had identical TCR ␣-chain nucleotide sequences. K14.2.D7, K14.13.D9, and K14.18.E7 (from one fusion) had identical TCR ␣-chain nucleotide sequences. K14.13.B3 and K14.20.D8 (from one fusion) had identical TCR ␣-chain nucleotide sequences. these T cells in the repertoire of the mice, because the repertoire expressed by TG8.1 mice is a subset of the T cells in wild-type mice. Similarly, the lack of response is not due to the absence of these epitopes due to differential processing, since these epitopes are recognized in the TG8.1 mice, which have an identical genetic background. Most likely, the differences are due to altered precursor frequency or relative affinity of T cells specific for these epitopes in wild-type and transgenic mice, factors that will affect the competition of TCRs for antigen during a viral infection. One prediction of this hypothesis is that wild-type mice can elicit a response to these subdominant epitopes after direct immunization with purified peptides. We are currently in the process of identifying the specific epitopes of NS-1 and M1 in order to determine the frequency of wild-type T cells that can respond to these epitopes and to determine the ability of these subdominant epitopes to protect wild-type mice from subsequent influenza virus infection. The ability to elicit a protective immune response to subdominant viral epitopes might be of relevance for the development of viral vaccines useful in outbred human populations.
Although it is generally believed that the TCR repertoire contributes to immunodominance, few studies have experimentally tested this hypothesis. Brändle et al. (10) studied the contribution of TCR ␣-and ␤-chains in recognizing viral epitopes from lymphocytic choriomeningitis virus (LCMV). These workers examined the epitope specificity and TCR usage of T cells from LCMV-infected single-chain transgenic mice that expressed either the TCR ␣-chain or TCR ␤-chain isolated from a V␣2 ϩ V␤8.1 ϩ CTL clone specific for LCMV. Whereas CTL from wild-type mice could recognize two different epitopes of LCMV glycoprotein (gp), expression of either transgene resulted in exclusive recognition of the gp epitope recognized by the CTL clone from which the transgene was isolated. This restricted pattern of epitope specificity was correlated with a strong selection for V␣2 ϩ V␤8.1 ϩ T cells in mice expressing either the ␣-chain or the ␤-chain transgene. These studies demonstrated that expression of a transgenic TCR ␣-or ␤-chain isolated from a virus-specific clone altered the pattern of immunodominance of viral epitopes after infection by reducing the number of epitopes recognized. Whereas a TCR element chosen for its reactivity to dominant viral determinants might be expected to bias the immunodominance of epitopes, our work analyzes the effect of an irrelevant TCR chain on epitope immunodominance during a viral infection.
The influence of the TCR repertoire on the immunodominance of class II-restricted epitopes has also been examined. Perkins et al. compared the responses of wild-type C57L mice, which have a deletion within the TCR ␤-chain locus that includes V␤8.2, and transgenic littermates that express a single TCR ␤-chain (V␤8.2D␤1.1J␤1.1C␤2) on all peripheral T cells to phage repressor (cI) (31) . The data revealed that different determinants of cI were immunodominant in the wild-type and transgenic mice. These workers also showed that this differential immunodominance was not a consequence of holes in the TCR repertoires of the respective mouse strains, because both wild-type and transgenic T cells could respond to either epitope following immunization with the appropriate peptide. Thus, a shift in immunodominance can occur despite the presence of some T cells specific for the original epitope. These studies on the immunodominance of class II-restricted epitopes involved the use of complete Freund's adjuvant, a potent immune enhancer. However, the work reported here shows the influence of the TCR repertoire on the immunodominance of class I-restricted epitopes during a viral infection. It is likely that infectious virus exerts a selective pressure on the immune response that would not be seen when peptides are used as the antigen. Therefore, our studies are physiologically relevant because we have used a pathogenic infectious virus as an antigenic challenge rather than synthetic peptides and immunization.
Taken together, the data reported here and published reports by others (28, 31) , support the hypothesis that the TCR repertoire makes a significant contribution to immunodominance. Whereas one or a few epitopes often dominate the T-cell response to antigen, many additional epitopes are potentially available to the T cells but appear to be ignored. However, T cells that recognize these subdominant epitopes can be elicited experimentally by direct peptide immunization (31) and/or perturbation of the TCR repertoire. Several factors, including endogenous superantigen-mediated deletion or anergy of T cells (20, 33, 34) , genetic deletions within the TCR ␤-chain locus (5, 24, 34) , and expression of different alleles of the TCR loci (38) , which are independent of MHC haplotype effects, can influence the diversity of the TCR repertoire and can therefore affect epitope recognition. Our data support the general concept that the TCR repertoire plays a major role in determining the immunodominance of epitopes and demonstrate a switch in the viral epitopes selected by class I-restricted T cells during an ongoing immune response.
